Literature DB >> 1870207

Activation of the c-ski oncogene by overexpression.

C Colmenares1, P Sutrave, S H Hughes, E Stavnezer.   

Abstract

The v-ski oncogene is a truncated version of the cellular proto-oncogene, c-ski, and lacks sequences coding for both the N- and C-terminal ends of the c-ski protein. In the region of overlap, v-ski and c-ski differ by only one amino acid. To determine whether these differences underlie v-ski's oncogenic activation, we have cloned cDNAs for several alternatively spliced c-ski mRNAs and introduced these cDNAs into replication-competent retroviral vectors. The biological activities of these c-ski constructs have been compared with those of v-ski. We found that all c-ski gene products, when expressed at high levels from the promoter in the retroviral long terminal repeat, can induce morphological transformation, anchorage independence, and muscle differentiation in avian cells. Cells that are susceptible to ski-induced transformation and myogenesis normally express endogenous c-ski at low levels. Thus, it appears that overexpression of ski is sufficient for oncogenic and myogenic activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870207      PMCID: PMC248954     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation.

Authors:  D Rosson; D Dugan; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  Isolation and characterization of three distinct cDNAs for the chicken c-ski gene.

Authors:  P Sutrave; S H Hughes
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

3.  Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA.

Authors:  C A Chen; H Okayama
Journal:  Biotechniques       Date:  1988 Jul-Aug       Impact factor: 1.993

4.  Activation of the trk oncogene by alternatively spliced muscle and non-muscle tropomyosin sequences.

Authors:  D Barnes; L Clayton; G Chumbley; A R MacLeod
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

5.  The v-ski oncogene encodes a truncated set of c-ski coding exons with limited sequence and structural relatedness to v-myc.

Authors:  E Stavnezer; D Brodeur; L A Brennan
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

6.  Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential.

Authors:  R A Feldman; W C Vass; P E Tambourin
Journal:  Oncogene Res       Date:  1987 Sep-Oct

7.  Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas.

Authors:  G L Shen-Ong; M Potter; J F Mushinski; S Lavu; E P Reddy
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

8.  Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified fos protein.

Authors:  W M Lee; C Lin; T Curran
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

9.  Isolation of human cDNA clones of ski and the ski-related gene, sno.

Authors:  N Nomura; S Sasamoto; S Ishii; T Date; M Matsui; R Ishizaki
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

10.  Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene.

Authors:  F Meijlink; T Curran; A D Miller; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

View more
  31 in total

1.  Ski interacts with the evolutionarily conserved SNW domain of Skip.

Authors:  T Prathapam; C Kühne; M Hayman; L Banks
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

2.  Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.

Authors:  S L Stroschein; S Bonni; J L Wrana; K Luo
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

3.  Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer.

Authors:  Yi Chen; Lucia Pirisi; Kim E Creek
Journal:  Virology       Date:  2013-06-27       Impact factor: 3.616

4.  C-ski cDNAs are encoded by eight exons, six of which are closely linked within the chicken genome.

Authors:  H L Grimes; B E Szente; M M Goodenow
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

5.  Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski.

Authors:  Katherine Marcelain; Ricardo Armisen; Adam Aguirre; Nobuhide Ueki; Jessica Toro; Clemencia Colmenares; Michael J Hayman
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

6.  c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion.

Authors:  Liyang Wang; Yixuan Hou; Yan Sun; Liuyang Zhao; Xi Tang; Ping Hu; Jiajia Yang; Zongyue Zeng; Guanglun Yang; Xiaojiang Cui; Manran Liu
Journal:  Mol Oncol       Date:  2013-08-27       Impact factor: 6.603

7.  Trans-regulation of myogenin promoter/enhancer activity by c-ski during skeletal-muscle differentiation: the C-terminus of the c-Ski protein is essential for transcriptional regulatory activity in myotubes.

Authors:  K Ichikawa; T Nagase; S Ishii; A Asano; N Mimura
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

8.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

9.  Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma.

Authors:  Thomas Longerich; Kai Breuhahn; Margarete Odenthal; Katharina Petmecky; Peter Schirmacher
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

10.  Oncogene and tumour suppressor: the two faces of SnoN.

Authors:  Samy Lamouille; Rik Derynck
Journal:  EMBO J       Date:  2009-11-18       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.